142 Real-world safety profile of pembrolizumab in nonsmall cell lung cancer (NSCLC): a retrospective analysis in NHS Tayside

Lung Cancer 2026

View at publisher

Authors: Ee Qing Thee, Ting Feng Ho, Hannah Lord

DOI: 10.1016/j.lungcan.2026.109091

Cited by: 0

References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

References 1